BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 35349797)

  • 1. Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study.
    Delgado-Alonso C; Valles-Salgado M; Delgado-Álvarez A; Yus M; Gómez-Ruiz N; Jorquera M; Polidura C; Gil MJ; Marcos A; Matías-Guiu J; Matías-Guiu JA
    J Psychiatr Res; 2022 Jun; 150():40-46. PubMed ID: 35349797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention impairment in motor functional neurological disorders: a neuropsychological study.
    Věchetová G; Nikolai T; Slovák M; Forejtová Z; Vranka M; Straková E; Teodoro T; Růžička E; Edwards MJ; Serranová T
    J Neurol; 2022 Nov; 269(11):5981-5990. PubMed ID: 35842882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological deficits in patients with cognitive complaints after COVID-19.
    García-Sánchez C; Calabria M; Grunden N; Pons C; Arroyo JA; Gómez-Anson B; Lleó A; Alcolea D; Belvís R; Morollón N; Mur I; Pomar V; Domingo P
    Brain Behav; 2022 Mar; 12(3):e2508. PubMed ID: 35137561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological, Medical, and Psychiatric Findings After Recovery From Acute COVID-19: A Cross-sectional Study.
    Ferrando SJ; Dornbush R; Lynch S; Shahar S; Klepacz L; Karmen CL; Chen D; Lobo SA; Lerman D
    J Acad Consult Liaison Psychiatry; 2022; 63(5):474-484. PubMed ID: 35085824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into attention and memory difficulties in post-COVID syndrome using standardized neuropsychological tests and experimental cognitive tasks.
    Arbula S; Pisanu E; Bellavita G; Menichelli A; Lunardelli A; Furlanis G; Manganotti P; Cappa S; Rumiati R
    Sci Rep; 2024 Feb; 14(1):4405. PubMed ID: 38388708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive profile in multiple sclerosis and post-COVID condition: a comparative study using a unified taxonomy.
    Delgado-Alonso C; Delgado-Alvarez A; Díez-Cirarda M; Oliver-Mas S; Cuevas C; Montero-Escribano P; Ramos-Leví AM; Gil-Moreno MJ; López-Carbonero JI; Hermann BP; Matias-Guiu J; Matias-Guiu JA
    Sci Rep; 2024 Apr; 14(1):9806. PubMed ID: 38684843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort.
    Schild AK; Goereci Y; Scharfenberg D; Klein K; Lülling J; Meiberth D; Schweitzer F; Stürmer S; Zeyen P; Sahin D; Fink GR; Jessen F; Franke C; Onur OA; Kessler J; Warnke C; Maier F
    J Neurol; 2023 Mar; 270(3):1215-1223. PubMed ID: 36422669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive complaints by hematopoietic cell transplantation recipients and change in neuropsychological performance over time.
    LaLonde L; Votruba K; Kentor R; Gatza E; Choi SW; Hoodin F
    Support Care Cancer; 2021 Jan; 29(1):247-254. PubMed ID: 32346799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: Cognitive functioning.
    Whiteside DM; Basso MR; Naini SM; Porter J; Holker E; Waldron EJ; Melnik TE; Niskanen N; Taylor SE
    Clin Neuropsychol; 2022 May; 36(4):806-828. PubMed ID: 35130818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment, psychiatric symptoms, and executive functioning in patients with Parkinson's disease.
    Petkus AJ; Filoteo JV; Schiehser DM; Gomez ME; Hui JS; Jarrahi B; McEwen S; Jakowec MW; Petzinger GM
    Int J Geriatr Psychiatry; 2020 Apr; 35(4):396-404. PubMed ID: 31894601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment in young adults with post COVID-19 syndrome.
    Herrera E; Pérez-Sánchez MDC; San Miguel-Abella R; Barrenechea A; Blanco C; Solares L; González L; Iza C; Castro I; Nicolás E; Sierra D; Suárez P; González-Nosti M
    Sci Rep; 2023 Apr; 13(1):6378. PubMed ID: 37076533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring cognitive and psychological alterations in COVID-19 patients: A longitudinal neuropsychological study.
    Diana L; Regazzoni R; Sozzi M; Piconi S; Borghesi L; Lazzaroni E; Basilico P; Aliprandi A; Bolognini N; Bonardi DR; Colombo D; Salmaggi A
    J Neurol Sci; 2023 Jan; 444():120511. PubMed ID: 36473347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of cognitive dysfunction one-year post COVID-19.
    Cavaco S; Sousa G; Gonçalves A; Dias A; Andrade C; Pereira D; Aires EA; Moura J; Silva L; Varela R; Malheiro S; Oliveira V; Teixeira-Pinto A; Maia LF; Correia M
    Neuropsychology; 2023 Jul; 37(5):557-567. PubMed ID: 36603126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long COVID neuropsychological follow-up: Is cognitive rehabilitation relevant?
    Braga LW; Oliveira SB; Moreira AS; Martins Pereira MEMDS; Serio ASS; Carneiro VDS; Freitas LFP; Souza LMDN
    NeuroRehabilitation; 2023; 53(4):517-534. PubMed ID: 38143394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between psychological distress, subjective cognitive complaints and objective neuropsychological functioning in brain tumor patients.
    Pranckeviciene A; Deltuva VP; Tamasauskas A; Bunevicius A
    Clin Neurol Neurosurg; 2017 Dec; 163():18-23. PubMed ID: 29035741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms.
    Calabria M; García-Sánchez C; Grunden N; Pons C; Arroyo JA; Gómez-Anson B; Estévez García MDC; Belvís R; Morollón N; Vera Igual J; Mur I; Pomar V; Domingo P
    J Neurol; 2022 Aug; 269(8):3990-3999. PubMed ID: 35488918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
    Hegedüs K; Kárpáti J; Iljicsov A; Simó M
    Mult Scler Relat Disord; 2019 Oct; 35():150-155. PubMed ID: 31376686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 severity is related to poor executive function in people with post-COVID conditions.
    Ariza M; Cano N; Segura B; Adan A; Bargalló N; Caldú X; Campabadal A; Jurado MA; Mataró M; Pueyo R; Sala-Llonch R; Barrué C; Bejar J; Cortés CU; ; Garolera M; Junqué C
    J Neurol; 2023 May; 270(5):2392-2408. PubMed ID: 36939932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Cognitive Outcome in Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
    Heine J; Kopp UA; Klag J; Ploner CJ; Prüss H; Finke C
    Ann Neurol; 2021 Dec; 90(6):949-961. PubMed ID: 34595771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of severe COVID-19: spotlight on fatigue, fatigability, multidomain complaints and pattern of cognitive deficits in a case series without prior brain dysfunction and without COVID-19-related stroke and/or cardiac arrest.
    Beaud V; Crottaz-Herbette S; Dunet V; Knebel JF; Bart PA; Clarke S
    J Med Case Rep; 2024 Feb; 18(1):64. PubMed ID: 38303088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.